‌

US Patent 9828408 HCV polymerase inhibitors

Patent 9828408 was granted and assigned to Medivir on November, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 28, 2017

Patent Application Number

15360360

Date Filed

November 23, 2016

Patent Citations Received

US Patent 12012431 Methods of preparing 1′-cyano nucleosides

0

US Patent 11939347 1′-cyano nucleoside analogs and uses thereof

0

US Patent 11975017 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

0

US Patent 11975012 Remdesivir treatment methods

0

US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs

0

US Patent 11751568 Picolinamide compounds with fungicidal activity

US Patent 11771085 Synergistic mixtures for fungal control in cereals

US Patent 11780844 Compounds and methods for treatment of viral infections

...

Patent Primary Examiner

Traviss C Mcintosh, III

Patent abstract

The invention provides compounds of the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9828408 HCV polymerase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.